FERMENTA BIOTECH LTD. Share Price

NSE: FERMENTA

₹ 432.05

+₹31.05 (7.74%)

Last updated 24 Jul, 2026, 15:53 IST

FERMENTA BIOTECH LTD. Share Price Today

As of 24 Jul 2026, FERMENTA BIOTECH LTD. share price is ₹432.05. The stock opened at ₹399.80, compared to its previous close of ₹401.00. During today's trading session, FERMENTA BIOTECH LTD. share price moved in the range of ₹395.15 to ₹435.40, with an average price of ₹415.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹248.85 and a high of ₹479.45. On the performance front, FERMENTA BIOTECH LTD. share price has increased by 28.44% over the last six months and is up 28.44% on a year-on-year basis.

₹395.15

7.74% up today

₹435.40

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 49.94% QoQ

Latest Earning

Net Profit TrendUp by 54.74% QoQ

Latest Earning

Revenue TrendUp by 13.82% YoY

Stock Performance

OutperformingBeat Nifty by 12.99 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 9625.00%

Shareholding Pattern

FIIFII increased stake by 410.89%

FERMENTA BIOTECH LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹6,78,470+₹1,78,470 (+35.69%)

3 Year

₹6,94,502+₹1,94,502 (+38.90%)

5 Year

₹6,94,502+₹1,94,502 (+38.90%)

₹320.80₹481.20

Circuit Low

Circuit High

₹248.85₹479.45

52-Week Low

52-Week High

Circuit

₹320.80

₹481.20

52-week

₹248.85

₹479.45

Mkt Cap Cr

1,182.98

P/E

12.75

P/B

2.25

ROE

18.27%

D/E

0.28

ROCE

20.68%

Div. Yield

1.15%

EPS(TTM)

20.43

Turnover

0.98

EV/EBITDA

7.58

Net Margin

14.28%

Op. Margin

27.22%

ROA

13.26%

Quick Ratio

0.00

Curr. Ratio

1.72

Mkt Cap Cr

1,182.98

P/E

12.75

P/B

2.25

ROE

18.27%

D/E

0.28

ROCE

20.68%

Div. Yield

1.15%

EPS(TTM)

20.43

Turnover

0.98

EV/EBITDA

7.58

Net Margin

14.28%

Op. Margin

27.22%

ROA

13.26%

Quick Ratio

0.00

Curr. Ratio

1.72

Based on fundamentals, this stock's

Performance

Excellent

Fermenta Biotec. outperforming all market indices

Valuation

Fairly Valued

Fermenta Biotec. appears to be fairly valued compared to its peers

Earnings

Good

Fermenta Biotec. revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,68,842.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.45	16.70%	10.19	0.20%	0.97	13.72

FERMENTA BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹525.43	₹469.48	₹335.66	₹349.94
Other Income	₹22.39	₹11.82	₹11.81	₹8.60
Total Revenue	₹547.81	₹481.30	₹347.47	₹358.54
Total Expenses	₹458.83	₹398.09	₹349.92	₹381.37
Profit Before Tax	₹95.86	₹83.21	-₹9.87	-₹51.31
Tax	₹25.61	₹6.81	₹14.14	₹1.83
Profit After Tax	₹70.25	₹76.40	-₹24.01	-₹53.13
EPS - Basic	₹24.70	₹26.35	-₹7.99	-₹17.70
EPS - Diluted	₹24.51	₹26.35	-₹7.99	-₹17.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹95.86	₹83.21	-₹9.87	-₹51.31
Income before WC changes	₹117.66	₹122.03	₹71.62	₹67.95
Change in Assets	-₹12.95	-₹91.10	₹13.24	₹42.94
Change in Liabilities	₹4.54	₹12.74	₹19.46	₹2.01
Change in WC	-₹8.41	-₹78.36	₹32.70	₹44.95
Cash flow from Operations	₹92.83	₹40.90	₹105.35	₹116.11
Cash flow from Investing	-₹43.00	-₹0.16	-₹15.50	-₹55.41
Cash flow from Financing	-₹42.29	-₹50.87	-₹90.85	-₹41.38
Total Cash Flow	₹7.55	-₹10.12	-₹1.00	₹19.32
Cash (Start of the year)	₹6.63	₹16.75	₹17.75	-₹1.61
Cash (End of the year)	₹14.18	₹6.63	₹16.75	₹17.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹259.92	₹279.24	₹306.08	₹383.49
Current Assets	₹388.02	₹335.23	₹241.75	₹253.02
Total Assets	₹647.94	₹614.48	₹547.83	₹636.52
Current Liabilities	₹208.77	₹211.88	₹173.26	₹208.72
Net Current Asset	₹179.25	₹123.36	₹68.49	₹44.31
Non-Current Liabilities	₹38.62	₹44.08	₹89.41	₹115.23
Equity Capital	₹400.55	₹358.52	₹285.16	₹312.56
Total Equity & Liabilities	₹647.94	₹614.48	₹547.83	₹636.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹450.25	₹430.53	₹307.09	₹328.91
Other Income	₹23.90	₹11.68	₹8.15	₹8.46
Total Revenue	₹474.15	₹442.21	₹315.24	₹337.38
Total Expenses	₹391.88	₹367.79	₹310.85	₹335.76
Profit Before Tax	₹89.24	₹74.42	-₹4.61	-₹57.98
Tax	₹24.96	₹6.81	₹14.14	-₹0.97
Profit After Tax	₹64.28	₹67.62	-₹18.74	-₹57.00
EPS - Basic	₹22.13	₹23.18	-₹6.49	-₹19.75
EPS - Diluted	₹21.96	₹23.18	-₹6.49	-₹19.75

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹89.24	₹74.42	-₹4.61	-₹57.98
Income before WC changes	₹108.79	₹110.60	₹80.82	₹88.87
Change in Assets	-₹2.71	-₹85.20	₹19.88	₹4.33
Change in Liabilities	-₹7.15	₹11.20	₹3.30	₹26.19
Change in WC	-₹9.85	-₹74.00	₹23.18	₹30.53
Cash flow from Operations	₹82.63	₹33.83	₹105.02	₹123.75
Cash flow from Investing	-₹44.50	₹0.41	-₹15.15	-₹63.53
Cash flow from Financing	-₹42.15	-₹50.91	-₹90.86	-₹41.25
Total Cash Flow	-₹4.02	-₹16.67	-₹0.98	₹18.97
Cash (Start of the year)	-₹3.12	₹13.56	₹14.54	-₹4.49
Cash (End of the year)	-₹8.64	-₹3.12	₹13.56	₹14.54

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹292.85	₹301.95	₹326.35	₹410.54
Current Assets	₹359.51	₹320.52	₹238.23	₹253.32
Total Assets	₹652.36	₹622.47	₹564.58	₹663.86
Current Liabilities	₹191.47	₹198.43	₹160.89	₹212.62
Net Current Asset	₹168.03	₹122.09	₹77.34	₹40.70
Non-Current Liabilities	₹38.07	₹44.08	₹89.46	₹115.18
Equity Capital	₹422.82	₹379.95	₹314.23	₹336.06
Total Equity & Liabilities	₹652.36	₹622.47	₹564.58	₹663.86

* All values are in INR Crore

Qty

Bid

645

432.05

Ask

Qty

Bid Total: 645

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

51.89

Neutral

ATR (14)

31.79

Neutral

STOCH(9,6)

13.7

Bullish

STOCH RSI (14)

Bullish

ADX(9)

32.73

Bearish

UO(9)

42.75

Neutral

ROC(12)

8.79

Bullish

WillR(14)

-58.72

Neutral

Period

Simple value

Exponential vaue

426.81

422.23

10D

435.56

421.5

20D

400.71

404.12

50D

350.32

382.05

100D

339.51

About FERMENTA BIOTECH LTD.

ISIN

INE225B01021

Sector Market Cap

₹ 1,182.98 Cr

Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.

FERMENTA BIOTECH LTD. Financial Highlights

Revenue: FERMENTA BIOTECH LTD. reported revenue of ₹547.82 crore in FY26 vs ₹481.30 crore in FY25. It showed an increase of 13.82% on a yearly basis.
Operating Profit: FERMENTA BIOTECH LTD. reported an operating profit of ₹95.86 crore in FY26 vs ₹83.21 crore in FY25. It showed an increase of 15.20% on a year-on-year basis.
Net Profit: FERMENTA BIOTECH LTD. reported a net profit of ₹70.25 crore in FY26 vs ₹76.40 crore in FY25. It showed a decrease of 8.05% on a yearly basis.

FERMENTA BIOTECH LTD. Quarterly Result Highlights

FERMENTA BIOTECH LTD. reported revenue of ₹126.64 crore in Mar 2026, compared with ₹140.48 crore in Dec 2025, representing a decrease of 9.85% on a quarter-on-quarter (QoQ) basis.
FERMENTA BIOTECH LTD. reported an operating profit of ₹26.21 crore in Mar 2026, compared with ₹17.48 crore in Dec 2025, representing an increase of 49.94% on a quarter-on-quarter (QoQ) basis.
FERMENTA BIOTECH LTD. reported a profit of ₹18.60 crore in Mar 2026, compared with ₹12.02 crore in Dec 2025, reflecting an increase of 54.74% on a QoQ basis.
The earnings per share (EPS) of FERMENTA BIOTECH LTD. stood at ₹24.70 during Mar 2026.